A recent study that used protein microarrays to screen for the presence of 30 aAbs in nasopharyngeal cancer patients also showed that NY-ESO-1 (along with cyclin B1, survivin, and IMP3) could serve as a biomarker for the detection of this type of cancer [97]. This evidence concerns the gene BIRC5 and cancer.